Pharmafile Logo

Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

February 1, 2022 | LATAM, Market Access, Mexico, Pharma 

Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.

In the first issue of our new online report series, Access All Areas, experts Rebeca Nana Barrentes and Tania Rodrigues investigate what the shake-up in Mexico’s drug market access landscape means for pharma.

Download now: https://bit.ly/3L0EGGj

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Webinar: Prescription Rationale: Physician Research via an iPhone App

This webinar explores the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription.

Maximising patient adherence by leveraging the patient/ physician/ pharma relationship

Director Marc Yates looks at the problem of patient compliance - can a better understanding of patient attitudes, needs and behaviours help pharma develop strategies to improve adherence?

Digital research in Asia

Director Marc Yates uses findings from a study conducted in six markets in Asia to explore how digital channels are being utilised by consumers and look at the digital opportunities...

Achieving customer centricity – Using immersion techniques to get closer to the pulse of the customer

Director Marc Yates discusses the importance of being customer-centric in the pharmaceutical industry and how immersion techniques in market research can help develop a better understanding of the customer.

The Mobile Revolution – Using mobile Apps to deliver “in-the-moment” market research to global healthcare

Director John Branston investigates the use of mobile research in order to capture immediate detailed, qualitative insights into prescription rationale at the patient level.